Christopher Martin's involvement with stock holdings shows interesting dynamics over the years. In 2019, he had a significant holding that generated over $900,000 from vested stock, showcasing his deep connection to the company's success. As of 2022, his balance in...

Recent Insider Trades

No insider trades found for this CEO.

Christopher Martin

Ex-CEO of ADC Therapeutics

CM

View Compensation History

2022 Total Compensation

$1.00M

Salary

$450.00K

Bonus

$0.00

Stock

$413.76K

Other

$139.24K